Screening for cervical cancer precursors by cytology has been very successful in countries
where adequate resources exist to ensure high quality and good coverage of the population …

Several studies suggest that HPV testing is more sensitive than cytology in primary cervical
screening. These studies had different designs and were reported in different ways …

The role of high-risk human papillomavirus (hrHPV) testing in primary cervical screening has
not been established. We generated a randomised evaluation design ultimately to clarify …

OBJECTIVE: We evaluated high-risk human papillomavirus (HPV) testing by Hybrid Capture
II (HC II) in addition to cytology to predict recurrent/residual cervical intraepithelial neoplasia …

Background Vaginal self-sampling for human papillomavirus (HPV) DNA testing could
increase rates of screening participation. In clinic-based settings, vaginal HPV testing is at …

High-risk human papillomaviruses (HR-HPV) are the necessary cause of cervical
carcinomas. To determine whether HPR-HPV DNA detection in primary routine screening …

Background Screening for cervical cancer based on testing for human papillomavirus (HPV)
increases the sensitivity of detection of high-grade (grade 2 or 3) cervical intraepithelial …

Although cytology-based cervical cancer prevention programs have reduced the incidence
of cervical cancer in many industrialized countries, the limited sensitivity of cervical cytology …

The knowledge that cervical neoplasia are caused by human papillomavirus (HPV) infection
has led to the evaluation of its role in screening. We evaluated the accuracy of HPV testing …

Background Cytology-based screening has been a cornerstone of cervical cancer
prevention for decades. Following extensive evidence demonstrating higher sensitivity and …